Cancer is a deadly disease. All of us know about these deadly diseases. Recently, Vaxil has developed a new treatment for cancer, named Immucin. It is a therapeutic vaccine that prepares the body’s immune system to end cancer cells.
The best thing about it is that the vaccine does not spoil the body’s good and healthy cells. The specialty of this treatment is that it gives very few side effects to the body. Because these treatments only promise to eliminate cancer cells, this treatment is effective.
The vaccine is given to sick people so that they can feel better. This is a kind of drug. It is a disease that makes our bodies produce multiple cell growth. Cancer cells grow rapidly. In this, our immune system stops responding and it becomes very difficult to fight the disease. In this case, there is a lot of weakness inside the person.
How this cancer vaccine treat the disease?
The vaccine improves the immune system of the sick person. The T-cells present in this vaccine end the cancer cells. In addition, these T cells also eliminate the marker on the cell wall of the cell. These marker cells release a protein called MUC1. These proteins make up 90 percent of cells. These proteins are released from cancer like lung, prostate, breast, colon, rectal, stomach, pancreatic, kidney, bladder, leukemia, lymphoma, myeloma, etc.
The Immucin vaccine can prove to be beneficial for a person in two ways. This vaccine is beneficial for a person of all ages. Every person’s immune system works differently and this vaccine is best for everyone. By adopting this treatment you can eliminate cancer. These treatments have been tried on those who had many types of myeloma (a kind of blood cancer). The vaccine will also be trialed on the remaining cancers which release MUC 1 proteins.
The vaccine will take 6-7 years to hit markets. This is the vaccine prepared by WaxHit Technologies. With this help, the researchers are trying to prepare the vaccine for the rest of the diseases like AIDS, Malaria, and Tuberculosis.
You must log in to post a comment.